12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Soleno Therapeutics (SLNO), Femasys (FEMY), DMK Pharmaceuticals (DMK), Immunovant (IMVT), Intercept Pharma (ICPT), and Applied Therapeutics (APLT) saw their shares rise, with Soleno Therapeutics leading the gainers with a 426.2% increase. On the other hand, TransCode Therapeutics (RNAZ), Fresh2 Group (FRES), Novo Integrated Sciences (NVOS), Candel Therapeutics (CADL), Know Labs (KNW), and Vaccitech (VACC) saw their shares decline, with TransCode Therapeutics leading the losers with a 71.7% decrease.
September 26, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Candel Therapeutics shares fell 15.19% to $0.95 during Tuesday's regular session.
The significant decrease in Candel Therapeutics' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Fresh2 Group stock fell 16.67% to $1.65 during Tuesday's regular session.
The significant decrease in Fresh2 Group's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Know Labs stock declined by 14.8% to $0.38 during Tuesday's regular session.
The significant decrease in Know Labs' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Novo Integrated Sciences shares declined by 16.11% to $0.22 during Tuesday's regular session.
The significant decrease in Novo Integrated Sciences' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics shares declined by 71.7% to $0.72 during Tuesday's regular session.
The significant decrease in TransCode Therapeutics' share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Vaccitech stock decreased by 14.25% to $2.71 during Tuesday's regular session.
The significant decrease in Vaccitech's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Applied Therapeutics shares moved upwards by 29.74% to $2.66 during Tuesday's regular session.
The significant increase in Applied Therapeutics' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
DMK Pharmaceuticals stock rose 160.42% to $1.18 during Tuesday's regular session.
The significant increase in DMK Pharmaceuticals' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Femasys shares rose 272.43% to $1.24 during Tuesday's regular session.
The significant increase in Femasys' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Intercept Pharma shares rose 78.87% to $18.68 during Tuesday's regular session.
The significant increase in Intercept Pharma's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Immunovant shares moved upwards by 101.08% to $40.78 during Tuesday's regular session.
The significant increase in Immunovant's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Soleno Therapeutics shares increased by 426.2% to $23.31 during Tuesday's regular session.
The significant increase in Soleno Therapeutics' share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100